Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma

Area of Science:

• Oncology
• Cell Biology
• Pathology

Background:

• CD44 is an adhesion molecule crucial for tumor cell interactions in metastasis.
• CD44v6 plays a role in the metastatic cascade, interacting with the endothelium and subendothelial matrix.
• Understanding CD44v6 expression in cervical cancer is vital for prognostic assessment.

Purpose of the Study:

• To investigate CD44v6 expression in uterine cervical cancers.
• To correlate CD44v6 expression with clinicopathologic prognostic variables.
• To examine the relationship between CD44v6 expression and patient survival.

Main Methods:

• Immunohistochemical analysis of CD44v6 expression in 88 uterine cervical cancer tissues.
• Comparison of tumoral CD44v6 expression with nonneoplastic tissue.
• Correlation with prognostic variables and survival analysis (Kaplan-Meier, Cox regression).

Main Results:

• Non-basal CD44v6 expression was significant in nonsquamous cancers, larger tumors (>3 cm), and recurrent tumors.
• Patient age correlated with disease-free survival.
• Tumor diameter, stromal invasion, lymph node involvement, general CD44v6, and non-basal CD44v6 expression predicted 5-year overall survival.
• Non-basal CD44v6 expression and lymph node involvement were independent predictors of overall survival.

Conclusions:

• CD44v6 expression is linked to prognostic variables in cervical carcinoma.
• CD44v6 expression predicts advanced pathological-surgical stage in early cervical cancer.
• Non-basal CD44v6 expression is a significant predictor of overall survival.